OnabotulinumtoxinA for Treatment of Moderate-to-Severe Horizontal Lines and Glabellar Lines from the Subject's Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.81 ◽

2017 ◽

Vol 1 ◽

pp. s82

Author(s):

Steven Dayan ◽

Patricia Ogilvie ◽

Alexander Z Rivkin ◽

Steven G Yoelin ◽

Julie K Garcia ◽

...

Keyword(s):

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Abstract Not Available Disclosures: Study supported by Allergan.

Download Full-text

Simultaneous Treatment of Moderate-to-Severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines wtih OnabotulinumtoxinA from the Subject's Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.87 ◽

2017 ◽

Vol 1 ◽

pp. s88

Author(s):

Steven Dayan ◽

Patricia Ogilvie ◽

Alexander Z Rivkin ◽

Steven G Yoelin ◽

Julie Garcia ◽

...

Keyword(s):

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Simultaneous Treatment ◽

Patient Reported

Abstract Not AvailableStudy supported by Allergan.

Download Full-text

Patient-reported outcomes (PROs) From TITAN: A phase 3, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

European Urology Supplements ◽

10.1016/s1569-9056(19)34587-7 ◽

2019 ◽

Vol 18 (11) ◽

pp. e3413-e3414

Author(s):

N. Agarwal ◽

K. Mcquarrie ◽

A. Bjartell ◽

S. Chowdhury ◽

A.J. Pereira De Santana Gomes ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Patient Reported Outcomes ◽

Androgen Deprivation ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Download Full-text

OnabotulinumtoxinA for treatment of moderate to severe horizontal frontalis lines and glabellar lines from the subject’s perspective: Patient-reported satisfaction and impact outcomes from a phase 3 double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.844 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB210

Keyword(s):

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Patient Reported

Download Full-text

Simultaneous treatment of moderate-to-severe horizontal frontalis lines, glabellar lines, and lateral canthal lines with onabotulinumtoxinA, from the subject’s perspective: Patient-reported satisfaction and impact outcomes from a phase 3 double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.1037 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB262

Keyword(s):

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Simultaneous Treatment ◽

Patient Reported

Download Full-text

Efficacy and Tolerability of Lasmiditan, an Oral 5-HT1F Receptor Agonist, for the Acute Treatment of Migraine: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study

SSRN Electronic Journal ◽

10.2139/ssrn.3228912 ◽

2018 ◽

Author(s):

Peter Goadsby ◽

Linda Wietecha ◽

Ellen Dennehy ◽

Bernice Kuca ◽

Michael Case ◽

...

Keyword(s):

Acute Treatment ◽

Receptor Agonist ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind

Download Full-text

SAT0423 Patient-Reported Quality of Life in Patients with Baseline Objective Signs of Inflammation and Active Nonradiographic Axial Spondyloarthritis Treated with Golimumab: Results of The Open-Label Extension of A Randomized, Double-Blind Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3020 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 824.1-824

Author(s):

W.P. Maksymowych ◽

M. Dougados ◽

J. Sieper ◽

J. Braun ◽

G. Bergman ◽

...

Keyword(s):

Quality Of Life ◽

Axial Spondyloarthritis ◽

Blind Study ◽

Double Blind Study ◽

Open Label ◽

Double Blind ◽

Patient Reported ◽

Open Label Extension ◽

Nonradiographic Axial Spondyloarthritis

Download Full-text

Patient-reported outcomes (PROs) from TITAN: A phase III, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

Annals of Oncology ◽

10.1093/annonc/mdz248.008 ◽

2019 ◽

Vol 30 ◽

pp. v330-v331

Author(s):

N. Agarwal ◽

K. McQuarrie ◽

A. Bjartell ◽

S. Chowdhury ◽

A J P D S Gomes ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Patient Reported Outcomes ◽

Androgen Deprivation ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Patient Reported

Download Full-text

N09C6 (Alliance) - A Phase 3, Randomized Double-Blind Study of Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiation Therapy With or Without Chemotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.11.014 ◽

2013 ◽

Vol 85 (1) ◽

pp. 21 ◽

Cited By ~ 3

Author(s):

R.C. Miller ◽

J. Leenstra ◽

R. Qun ◽

J.A. Martenson ◽

K.J. Dornfeld ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck ◽

Oral Mucositis ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Head And Neck Radiation

Download Full-text

Placebo-Controlled, Double-Blind Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia Including Those With Gout in Japan; Phase 3 Clinical Study

JCR Journal of Clinical Rheumatology ◽

10.1097/01.rhu.0000453965.90144.b4 ◽

2014 ◽

Vol 20 (6) ◽

pp. E1

Keyword(s):

Clinical Study ◽

Xanthine Oxidase ◽

Oxidase Inhibitor ◽

Blind Study ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Xanthine Oxidase Inhibitor

Download Full-text

5.21 EVALUATION OF THE EFFICACY AND SAFETY OF SHP465 MIXED AMPHETAMINE SALTS AT A LOW DOSE IN CHILDREN WITH ADHD: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2019.08.335 ◽

2019 ◽

Vol 58 (10) ◽

pp. S252

Author(s):

Greg Mattingly ◽

Valerie Arnold ◽

Brian Yan ◽

Ming Yu ◽

Brigitte Robertson

Keyword(s):

Low Dose ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Children With Adhd

Download Full-text